Lakefront Biotherapeutics NV (GLPG) Form 6-K — Oct 20, 2026
Lakefront Biotherapeutics repurchased 107,804 of its own shares between October 12 and October 16, 2026, spending €2,854,365.69 at an average price of €26.48. The purchases were executed via a discretionary mandate to an independent financial intermediary under the buyback program announced June 9, 2026. With these purchases, the repurchase program announced on June 9, 2026 has been fully completed.
Key figures
- Price Range Eur
- 26.04 - 26.98
- Average Price Eur
- 26.48
- Shares Repurchased
- 107804
- Treasury Shares Held
- 1985157
- Program status
- fully completed
- Program announced
- 2026-06-09
- Repurchase period
- 2026-10-12 to 2026-10-16
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.